We recently updated our soy research page with a 2019 dose-response meta-analysis of 23 prospective studies. It included a total of 330,826 participants and found that both soy protein and soy isoflavones had a positive impact on breast cancer mortality (1). A 10 mg/day increase in soy isoflavone intake was associated with a 9% decreased risk of breast cancer mortality, and a 5 g/day increase in soy protein intake was associated with a 12% reduction in breast cancer death (1).
You may also like
The absorption section of our Vitamin A article has been updated with information addressing a genetic predisposition for being a “low responder” […]
A report, published in September 2019, on cardiovascular events among vegetarians in the EPIC-Oxford cohort garnered much media attention with its striking […]
by Jack Norris, RD, LD We’ve added two appendices to our article, Omega-3s Part 2: Research: Appendix A: Biomarkers of DHA Status […]
This week, the American College of Physicians released a dietary guideline for red and processed meat. The guideline, published in the Annals […]